Prelude – by Scott Marsland, FNP-C

Feb 28, 2024 | Scott Marsland Substack

[ad_1]

Everyone has their story to tell. What prompts me to offer mine is in part what I have learned from my faith and practice as a Quaker. Seeking guidance and solace from God, we share when the spirit rises within us, in the hope that sharing benefits others.

My favorite stories have been those which toggle back and forth between the present, the recent past, and the distant past. Also known as history. May I even approach the shadow of the skill of those hard working writers.

I’ll endeavor to post weekly, for as long as the story takes to tell. It will be personal, but intended to lift us up, together.

Today I am partners in a telemedicine practice which focuses on post acute sequelae of COVID, PASC or long-haul; and injury from the COVID vaccines. Our team has evaluated and treated nearly four thousand people since early 2022, prescribing repurposed drugs to keep people out of the hospital, effectively treating acute COVID, and wrestling with the hydra of PASC and vaccine injury. We know what we are up against, and it is daunting. Yet we have managed to learn a great deal, and get better and better at what we do. There aren’t many practitioners in the world who know what we know. There should be.

In February of 2020, I was working as an RN at SUNY Upstate Medical University in the Emergency Department. Upstate is a Level 1 trauma center. In the middle of a shift, I swiftly fell ill, developing a fever, chills, and general malaise. I think that I was assigned to trauma that day. When I told my co-workers that I was having chills and would have to go, they thought I was joking. I knew that I had an hour and a half drive ahead of me, and things were going South quickly. My life hasn’t been the same since. But then whose life is today what it was in February of 2020?

When I was in third grade, I was in Mr Stevens’ class. He wore cardigans, horn rimmed glasses, and drove a faded black Volkswagen Bug. I was the class clown that year. He and I were not friends. We had a beautiful student teacher who I had a crush on; probably most of the boys did. For reasons that my 3rd grade boy brain couldn’t fathom, she announced one day that we were going to have a vote. She wanted to know if the class wanted to be divided up into boys on one side, and girls on the other, or if we wanted to remain mixed together as we had been for most of the year. Boys voted first. Boys wanting to keep it mixed. I raised my hand. No one else did. Then all the other boys voted to be separated, and all the girls agreed. Ms Student Teacher wasn’t done yet though, and said, “Well Scott, it looks like you are the only want who wants the boys and girls to sit together. That’s not normal. The rest of your classmates voted differently, so we’re going to rearrange the room now.”

I didn’t get it. I didn’t understand why my classmates would want to lose the connections we had, to begin building walls, to be manipulated by a relative newcomer, an adult, because it would make her life easier. I used to think this was a hurtful event in my young life. Well, it was, but life since COVID has changed my perspective a bit. That early experience prepared me to call things as I see them, to not be afraid to diverge from my peers, and, darn it all, to expect the crowd to be easily lead down the garden path.

[ad_2]

Source link

The Need For More Accessible and Effective Cancer Treatment

Tens of billions of dollars are poured into cancer research every year. In the US alone, over $200 billion dollars are spent annually by cancer patients for treatment. Some studies show that these patients are 2-4x more likely to declare bankruptcy. However, despite all this money, there has been very little improvement in patient outcomes. Multiple studies demonstrate that this research apparatus has done very little to help ease the burden of suffering. For instance, take the following data sets:

  • A 25 year set of data from the U.S. indicated that 5-year cancer survival rates have only increased by 5% (63% to 68%)
  • Improvement in overall survival by new cancer therapies is just 2.4 months over the last 15 years (Ladanie et al)
  • Over the last 30 years, another study reports an improvement of 3.4 months (Del Paggio et al).

Furthermore, there are significant and valid concerns regarding side effects associated with conventional cancer treatment. The literature shows high prevalence of long-term issues leading to reduced quality of life, and even treatment discontinuation. Some commonly reported side effects include:

  • Fatigue (59%)
  • Sleep Disorders (41%)
  • Neuropathy (38%)
  • Pain (36%)
  • Secondary Cancer (doubled risk)

 

Between the financial burden, poor outcomes, and the side effects, there is an undisputed need to identify cheap, safe, and effective treatments that are accessible to all. In this piece, we will explore the ways in which Ivermectin checks all three boxes.

 

 

Opus Health logo

Leading Edge Clinic has partnered with Opus Health to help patients unlock HSA/FSA funds and save on care.

Click this popup to learn more